Nuvation Bio Inc. (NUVB) is a publicly traded Healthcare sector company. As of May 20, 2026, NUVB trades at $4.44 with a market cap of $1.47B and a P/E ratio of -10.73. NUVB moved +6.49% today. Year to date, NUVB is -47.50%; over the trailing twelve months it is +107.83%. Its 52-week range spans $1.54 to $9.75. Analyst consensus is strong buy with an average price target of $13.17. Rallies surfaces NUVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nuvation Bio Inc. (NUVB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NUVB moved +6.49% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $4.44 |
| Market Cap | $1.47B |
| P/E Ratio | -10.73 |
| EPS | $-0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.75 |
| 52-Week Low | $1.54 |
| Volume | 4.47M |
| Avg Volume | 0 |
| Revenue (TTM) | $143.05M |
| Net Income | $-145.99M |
| Gross Margin | 0.00% |
7 analysts cover NUVB: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.17.